LETTER TO THE EDITOR
 
TOPICS
REFERENCES (21)
1.
Tuohy EL. A case of splenomegaly with polymorphonuclear neutrophil hyperleukocytosis. Am J Med Sci 1920; 160: 18-24.
 
2.
Li B, Gale RP, Xiao Z. Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia. J Hematol Oncol 2014; 7: 93.
 
3.
Tefferi A, Thiele J, Vardiman JW. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer 2009; 115: 3842-7.
 
4.
Vardiman JW, Brunning RD, Harris NL. WHO histological classification of chronic myeloproliferative diseases. 2001.
 
5.
Kumar SK, Callander NS, Adekola K, et al. Multiple myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2023; 21: 1281-301.
 
6.
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127: 2391-405.
 
7.
Dao KT, Tyner JW, Gotlib J. Recent progress in chronic neutrophilic leukemia and atypical chronic myeloid leukemia. Curr Hematol Malig Rep 2017; 12: 432-41.
 
8.
Maxson JE, Gotlib J, Pollyea DA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med 2013; 368: 1781-90.
 
9.
Elliott MA, Pardanani A, Hanson CA, et al. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia. Am J Hematol 2015; 90: 653-6.
 
10.
Böhm J, Kock S, Schaefer HE, Fisch P. Evidence of clonality in chronic neutrophilic leukaemia. J Clin Pathol 2003; 56: 292-5.
 
11.
Elliott MA, Hanson CA, Dewald GW, Smoley SA, Lasho TL, Tefferi A. WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature. Leukemia 2005; 19: 313-7.
 
12.
Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985; 229: 16-22.
 
13.
Pardanani A, Lasho TL, Laborde RR, et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia 2013; 27: 1870-3.
 
14.
Guo YJ, Wang Y, Wang LH, et al. Analysis of clinical features and prognosis of patients with chronic neutrophil leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2020; 28: 82-7.
 
15.
Ouyang Y, Qiao C, Chen Y, Zhang SJ. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia. Oncotarget 2017; 8: 20834-41.
 
16.
Szuber N, Finke CM, Lasho TL, et al. CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival. Blood Cancer J 2018; 8: 21.
 
17.
Fleischman AG, Maxson JE, Luty SB, et al. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition. Blood 2013; 122: 3628-31.
 
18.
Lasho TL, Mims A, Elliott MA, Finke C, Pardanani A, Tefferi A. Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib. Leukemia 2014; 28: 1363-5.
 
19.
Wu XB, Wu WW, Zhou Y, Wang X, Li J, Yu Y. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review. BMC Cancer 2018; 18: 343.
 
20.
Guastafierro V, Ubezio M, Manes N, Milanesi C, Della Porta M, Bonometti A. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature. Leuk Lymphoma 2023; 64: 1566-73.
 
21.
Shi J, Ni Y, Li J, Qiu H, Miao K. Concurrent chronic neutrophilic leukemia blast crisis and multiple myeloma: a case report and literature review. Oncol Lett 2015; 9: 2208-10.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top